Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
5.35
-0.03 (-0.56%)
At close: Dec 5, 2025
30.81% (1Y)
| Market Cap | 17.74B |
| Revenue (ttm) | 5.88B |
| Net Income (ttm) | 459.25M |
| Shares Out | n/a |
| EPS (ttm) | 0.31 |
| PE Ratio | 38.63 |
| Forward PE | n/a |
| Dividend | 0.27 (5.05%) |
| Ex-Dividend Date | May 26, 2025 |
| Volume | 1,068,500 |
| Average Volume | 786,075 |
| Open | 5.37 |
| Previous Close | 5.38 |
| Day's Range | 5.26 - 5.37 |
| 52-Week Range | 3.56 - 7.26 |
| Beta | 0.43 |
| RSI | 43.36 |
| Earnings Date | Mar 26, 2026 |